Among the targeted lung‐cancer‐associated sEV makers (i.e., THSB2, VCAN, and TNC), we selected TNC for sEV capture because it was consistently expressed across the tested lung cancer cell lines (Figure 2d) used in this study. This evidence concerns the gene VCAN and lung cancer.